絞り込み

16426

広告

奄美ノネコ捕獲計画案、1週間期限譲渡先探す - 読売新聞

読売新聞奄美ノネコ捕獲計画案、1週間期限譲渡先探す読売新聞世界自然遺産登録を目指す奄美大島で野生化したネコ(ノネコ)が固有種を襲っている問題で、環境省と鹿児島県...

  1. 福島第1、屋根カバー設置を完了 (デイリ...
  2. Tesla、パブリッククラウド環境に不正...
  3. どうなる、地球温暖化時代の「冬季五輪」 ...
  4. [企業] Ionis 腎疾患治療アンチセ...

ニュース一覧

When adverse effects are seen as desirable: Abuse potential of the newer generation antiepileptic drugs.

著者 Hawkins KL , Gidal BE
Epilepsy Behav.2017 Oct 27 ; 77():62-72.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (37view , 0users)

Full Text Sources

There has been growing recognition of the possible abuse potential of newer generation antiepileptic drugs, and several of these agents have been categorized as controlled substances in the United States. To properly schedule a new medication, the abuse potential, or the potential for a drug to be used for its nonmedical positive subjective effects, must be determined. Performing a human abuse potential study is one step in the overall abuse potential assessment. These studies analyze the abuse potential of a new drug in a very specific population of known recreational drug users. Studying the test drug in this population enables a more meaningful assessment of abuse, and likely represents the population most probable to abuse. In these double-blind, single-dose, active and placebo controlled studies subjects may report their subjective liking, estimated street value, and rate euphoric or depressive sensations of the test drug compared with placebo and scheduled active comparators with a known abuse potential. In order to provide an enhanced understanding of the abuse potential assessment and how it relates to controlled substance scheduling, this review will examine the human abuse potential studies of perampanel, eslicarbazepine, lacosamide, and brivaracetam.
PMID: 29111505 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード